How to buy Erytech Pharma S-AADR stock (ERYP)

Erytech Pharma S-AADR is a biotechnology business based in the US. Erytech Pharma S-AADR shares (ERYP) are listed on the NASDAQ and all prices are listed in US Dollars. Erytech Pharma S-AADR employs 49 staff and has a trailing 12-month revenue of around $6.6 million.

Our top picks for where to buy Erytech Pharma S-AADR stock

Buy Erytech Pharma S-AADR stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Erytech Pharma S-AADR stock price (NASDAQ: ERYP)

Use our graph to track the performance of ERYP stocks over time.

Erytech Pharma S-AADR shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.86
200-day moving average more info button	$0.74
Wall St. target price	$2.96
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.01

Is it a good time to buy Erytech Pharma S-AADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Erytech Pharma S-AADR financials

Revenue TTM	$6.6 million
Gross profit TTM	$4.2 million
Return on assets TTM	-30.14%
Return on equity TTM	-0.98%
Profit margin	-3.43%
Book value	$0.76
Market Capitalization more info button	$47.4 million

TTM: trailing 12 months

Erytech Pharma S-AADR share dividends

We're not expecting Erytech Pharma S-AADR to pay a dividend over the next 12 months.

Erytech Pharma S-AADR share price volatility

Over the last 12 months, Erytech Pharma S-AADR's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Erytech Pharma S-AADR's is 2.1291. This would suggest that Erytech Pharma S-AADR's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Erytech Pharma S-AADR overview

PHAXIAM Therapeutics S. A. , a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-"-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. The company was formerly known as ERYTECH Pharma S. A.

Frequently asked questions

null
What percentage of Erytech Pharma S-AADR is owned by institutions?
Currently 7.652% of Erytech Pharma S-AADR shares are held by institutions. How many people work for Erytech Pharma S-AADR?
Latest data suggests 49 work at Erytech Pharma S-AADR. When does the fiscal year end for Erytech Pharma S-AADR?
Erytech Pharma S-AADR's fiscal year ends in December. Where is Erytech Pharma S-AADR based?
Erytech Pharma S-AADR's address is: 60 Avenue Rockefeller, Lyon, France, 69008 What is Erytech Pharma S-AADR's ISIN number?
Erytech Pharma S-AADR's international securities identification number is: US29604W1080 What is Erytech Pharma S-AADR's CUSIP number?
Erytech Pharma S-AADR's Committee on Uniform Securities Identification Procedures number is: 29604W108